SCHEMBL31122672

SCHEMBL31122672

c1ccc2cc3c(-c4coc5c4ccc4c6ccccc6ccc45)c(-c4cccc5ccc6cc7ccccc7cc6c45)ccc3cc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 6/20 0.39
▸ FYN P06241 2/20 0.39
▸ ACHE P22303 2/20 0.39
▸ AHR P35869 2/20 0.39
▸ ERBB2 P04626 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ ALDH1A1 P00352 7/20 0.36
▸ HSD17B10 Q99714 5/20 0.36
▸ HPGD P15428 5/20 0.36
▸ HIF1A Q16665 4/20 0.36
▸ MAPK1 P28482 3/20 0.36
▸ TSHR P16473 2/20 0.36
▸ CASP1 P29466 2/20 0.36
▸ ANPEP P15144 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CES1 P23141 1/20 0.35
▸ CYP1B1 Q16678 2/20 0.35
▸ SOS1 Q07889 1/20 0.34
▸ HPRT1 P00492 3/20 0.33
▸ TP53 P04637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31122703 0.99 ALDH1A1 (0.38) CYP1A2FYNACHEAHRERBB2
SCHEMBL30302745 0.94 ALDH1A1 (0.40) CYP1A2FYNACHEAHRERBB2
SCHEMBL30302759 0.94 ALDH1A1 (0.40) CYP1A2FYNACHEAHRERBB2
SCHEMBL30302747 0.93 ALDH1A1 (0.39) CYP1A2FYNACHEAHRERBB2
SCHEMBL30302761 0.92 ALDH1A1 (0.38) CYP1A2FYNACHEAHRERBB2
SCHEMBL30302706 0.91 ALDH1A1 (0.38) CYP1A2FYNACHEAHRERBB2
SCHEMBL30302943 0.91 CYP1A2 (0.44) CYP1A2FYNACHEAHRERBB2
SCHEMBL30302693 0.90 ALDH1A1 (0.37) CYP1A2FYNACHEAHRERBB2
SCHEMBL30302829 0.89 ALDH1A1 (0.41) CYP1A2FYNACHEAHRERBB2
SCHEMBL30302821 0.89 ANPEP (0.36) CYP1A2FYNACHEAHRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240407244-A1 MIXED POWDER FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND METHOD FOR PRODUCING THE SAME, METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE BY USING THE MIXED POWDER, METHOD FOR SELECTING COMPOUNDS IN THE MIXED POWDER, AND COMPOSITION FOR VACUUM DEPOSITION IDEMITSU KOSAN CO.,LTD. (JP) 2024-12-05 — — US disclosed
US-20240334814-A1 MIXED POWDER, MIXTURE, AND METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-10-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240334814-A1 MIXED POWDER, MIXTURE, AND METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE EML4, ORC3, ZRANB2 CYP1A2 2092/4885FYN 1575/4885ACHE 481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback